The recent advancements in our biosensor technology mark a significant step forward in the fields of diagnostics and environmental monitoring. With its high sensitivity, multiplexing capability, and robust design, the rGO-based biosensor is poised to become a transformative tool in medical and environmental applications.
This is significant because early-stage cancer detection, as enabled by the biosensor’s ability to detect biomarkers like Carcinoembryonic Antigen (CEA) at clinically relevant levels, can dramatically improve treatment outcomes and patient survival rates.
Similarly, its successful application in detecting SARS-CoV-2 during the pandemic highlighted its potential to respond rapidly to emerging health crises, enabling timely and accessible diagnostics. Beyond healthcare, the biosensor’s role in environmental monitoring, such as detecting trace pollutants and pathogens in water, addresses critical global challenges like water quality and safety. These capabilities underscore its versatility and societal impact, ensuring that it can serve as a cost-effective, scalable solution for pressing issues in healthcare and environmental sustainability. As we move toward commercialization, our focus remains on ensuring widespread accessibility and impact, continuing to innovate in this critical domain.
The global COVID-19 pandemic may be in the rear-view mirror, but the research world is still working hard on the umpteen questions that arose throughout the crisis. Some of these mysteries involve long COVID and why some people get it and others don’t.
People with long COVID continue to exhibit symptoms for months or even years after testing negative for the virus. The most common symptoms include extreme fatigue; brain fog or memory problems; dizziness; and trouble with smell or taste.
A recent study published in npj Digital Magazine might help predict who is most at risk.
The research suggests that individuals experiencing long-term symptoms after a SARS-CoV-2 infection exhibit distinct physiological characteristics detectable through wearable devices.
Twenty thousand people were monitored via wearable devices; the commonality among those with long COVID revealed those individuals had a higher resting heart rate and lower step count.
Long COVID was shown to affect those with generally lower quality of life and overall well-being, suggesting lower fitness levels and/or pre-existing conditions may contribute to the severity of post-COVID-19 conditions.
The research also indicated possible value in wearable technology in tracking health trends and identifying those at higher risk for long COVID.
More like this: What we know about long covid
